Ultragenyx Pharmaceutical (RARE) Gross Margin Growth (1y) (2019 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Gross Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn | 526.00 |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn | -5.00 |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn | -165.00 |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn | 21,616.00 |
| 10 | Ultragenyx Pharmaceutical | 2.29 Bn | 1.89 Bn | 106.00 Mn | -120.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -120.00 |
| Dec 31, 2025 | -373.00 |
| Sep 30, 2025 | -243.00 |
| Jun 30, 2025 | 66.00 |
| Mar 31, 2025 | -475.00 |
| Dec 31, 2024 | -111.00 |
| Sep 30, 2024 | -386.00 |
| Jun 30, 2024 | -532.00 |
| Mar 31, 2024 | -391.00 |
| Dec 31, 2023 | -417.00 |
| Sep 30, 2023 | -169.00 |
| Jun 30, 2023 | 10.00 |
| Mar 31, 2023 | -457.00 |
| Dec 31, 2022 | -94.00 |
| Sep 30, 2022 | -440.00 |
| Jun 30, 2022 | -565.00 |
| Mar 31, 2022 | -241.00 |
| Dec 31, 2021 | 178.00 |
| Sep 30, 2021 | -223.00 |
| Jun 30, 2021 | -68.00 |
| Mar 31, 2021 | 443.00 |
| Dec 31, 2020 | 836.00 |
| Sep 30, 2020 | 752.00 |
| Jun 30, 2020 | 25.00 |
| Mar 31, 2020 | -716.00 |
| Dec 31, 2019 | -1,123.00 |
| Sep 30, 2019 | -808.00 |
| Jun 30, 2019 | -207.00 |
| Mar 31, 2019 | -38.00 |